Drug Shortage Report for CLAVULIN 250 F ORAL SUS

Last updated on 2022-10-27 History
Report ID 166417
Drug Identification Number 01916874
Brand name CLAVULIN 250 F ORAL SUS
Common or Proper name amoxicillin / clavulanate potassium for oral suspension
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) CLAVULANIC ACID AMOXICILLIN
Strength(s) 62.5MG 250MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 100ML
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-08-05
Estimated end date 2022-11-30
Actual end date 2022-10-26
Shortage status Resolved
Updated date 2022-10-27
Company comments Supply released October 14, 2022 with limited quantity. Inventory on allocation to support demand.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2022-10-27 English Compare
v10 2022-10-26 French Compare
v9 2022-10-26 English Compare
v8 2022-10-21 French Compare
v7 2022-10-21 English Compare
v6 2022-10-12 French Compare
v5 2022-10-12 English Compare
v4 2022-09-14 French Compare
v3 2022-09-14 English Compare
v2 2022-08-10 French Compare
v1 2022-08-10 English Compare

Showing 1 to 11 of 11